Phone: (212) 746-5788
Fax: (212) 746-0975
March 29, 2010 11:52 am
Glaxo re-submits Avodart cancer filing - Reuters
Google News - Prostate Cancer
Glaxo re-submits Avodart cancer filing Reuters L) has re-submitted its application to US regulators for a new use of its Avodart drug in preventing prostate cancer. The British-based drugmaker withdrew ... GSK ups stake in JCR, refiles Avodart for prostate cancer GSK Regulatory Update - Avodart (dutasteride) |
|